Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II ...

Japan's TRG-035 drug targets tooth regrowth proteins in human trials, offering hope for dental replacement beyond implants by ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in genetics, molecular biology, and regenerative medicine, that dream is ...

Losing teeth has meant artificial replacements for centuries. Japanese researchers at Kyoto University Hospital are changing that with human trials of a drug that regrows natural teeth. By 2030, ...

First highlighted as part of a study in 2021, a tooth-regrowing drug is set to finally enter human testing this year. We covered plans for the drug to come to clinical trials last year, and now, it ...